|
Previously Senior Medical Director and World Wide Team Leader, Schizophrenia for Pfizer Global Pharmaceuticals, Inc.
Over 5 years of clinical research and clinical development strategy experience in the pharmaceutical industry.
Stephen Murray, M.D., Ph.D. From 2004 to 2006, Dr. Murray, served as Senior Medical Director, Worldwide Medical Team Leader, Schizophrenia and Full Development Team Leader for Ziprasidone. From 2001 to 2004, Dr. Murray was a Medical Director with Pfizer Pharmaceutics Group, Inc., where he was responsible for the Phase 3b and Phase 4 clinical trials for Ziprasidone. From 1999 2001, Dr. Murray was an Associate Medical Director of Global CNS Clinical Research & Development with Janssen Research Foundation. Prior to joining Janssen, Dr. Murray was in private practice. From 1992 1998, Dr. Murray completed his Internship, Residency and Fellowship at the Department of Psychiatry at the University Of California, San Francisco. Dr. Murray received his M.D. and Ph.D. in molecular biology from the Medical University of South Carolina, Medical Scientist Training Program in 1992 and his Bachelor of Science from the University of South Carolina, South Carolina College, in 1985. Dr. Murray has authored/co-authored original research in such journals as the American Journal of Psychiatry and Science, made over a hundred presentations at international congresses and meetings, and is a member of the American Board of Psychiatry and Neurology.
| 